Astec LifeSciences Limited has informed the Exchange regarding Appointment of Mr Vishal Sharma as Additional Director (Non-Executive & Non-Independent Director) and Chairperson of the Board of Directors of the company w.e.f. close of business hours on April 13, 2026.
ASTEC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Astec LifeSciences underwent significant leadership changes on April 13, 2026. Long-time Chairman Mr. Nadir Godrej (74) retired and stepped down from the Board to pursue other interests. Mr. Vishal Sharma, currently Executive Director & CEO (Chemicals) at Godrej Industries Limited (the Ultimate Holding Company), has been appointed as the new Chairperson and Additional Director (Non-Executive, Non-Independent) of Astec, subject to shareholder approval. Additionally, Mr. Burjis N. Godrej (son of Nadir Godrej) resigned as Managing Director with immediate effect to focus on Godrej Agrovet Limited (parent company) but will continue as a Non-Executive Director. Two more appointments were made: Mr. Mathew Eipe (former Executive Director at Godrej Industries) joins as an Independent Director, and Mr. Arijit Mukherjee (existing COO) has been elevated to Executive Director & COO. The Board will now comprise 10 directors with 50% independent directors.
The leadership transition marks an end of an era for Astec under the Godrej family, with new external leadership from the holding company taking over the chairperson role. While the resignation of the Managing Director and retirement of the Chairman may cause some short-term uncertainty, the appointment of experienced industry veterans and retention of promoter family on the board provides continuity and may reassure long-term investors.